Healthcare organizations tackle AI governance in fragmented regulatory environment

Healthcare organizations face fragmented regulatory environments across major regions like the US, EU, and China that complicate AI governance and data management, affecting drug discovery, clinical trials, and patient care. Industry leaders emphasise the need for consensus privacy safeguards and flexible, yet robust, governance to balance innovation with patient safety risks from AI tools.

This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, AI Infrastructure and Biotech.